at the optimal doses , 4-demethoxydaunorubicin was markedly more active than daunorubicin or doxorubicin in mice injected iv with 10 ( 5 ) l1210 leukemia cells ( early or late leukemia ) or with 10 ( 2 ) gross leukemia cells .
C0020789
4-demethoxydaunorubicin
C0011015
daunorubicin